Thursday, January 13, 2022 2:01:41 PM
Why did Dr Fish choose little 'ol Arch Therapeutics?
Bio:
Guy Fish, MD, MBA, has extensive health care experience as a physician and a consultant in numerous executive leadership roles which encompass both the for-profit and nonprofit health care sectors. Before joining GLFHC in July 2021, Fish was acting CEO of Nextstage Therapeutics, a Spanish company with exosome technologies. Prior to that, he was CEO of Cellanyx Diagnostics, which uses artificial intelligence to predict which cancers are aggressive and which are not. Before Cellanyx, Fish was a leader with profit and loss responsibilities for 17 years at the health care strategy consulting firm Fletcher Spaght, Inc. His market assessments, due diligence in acquisitions, fundraising, and strategic growth planning for a wide range of medical services and products resulted in substantial value creation over the last ten years. In the nonprofit sector, Fish is Chairman of the Board of Trustees at health care think-tank Altarum Institute which is focused on improving the health of marginalized communities. As treasurer of the Harvard Alumni Association, he spearheaded initiatives to advance social justice and anti-racism. Fish is also a Lay Trustee of the Beth Israel Deaconess Medical Center and has chaired both the Patient Care Committee and the Medical Education Committee.
https://glfhc.org/about/leadership-team/
Stock discussion boards would be so much more fun if liars' pants really did catch on fire.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM